What PACIFICARE HEALTH SYSTEMS INC /DE/'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Disposition to Issuer · D | −19,315 | $90.87 | −$1.76M | 0 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Disposition to Issuer · D | −5,969 | $90.87 | −$542K | 19,315 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Withheld — tax / exercise cost · F | −5,031 | $90.87 | −$457K | 25,284 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Exercise / conversion · M | +11,000 | — | — | 30,315 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Disposition to Issuer · D | −9,044 | $90.87 | −$822K | 19,315 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Withheld — tax / exercise cost · F | −7,623 | $90.87 | −$693K | 28,359 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Exercise / conversion · M | +16,667 | — | — | 35,982 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Disposition to Issuer · D | −14,662 | $90.87 | −$1.33M | 19,315 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Withheld — tax / exercise cost · F | −12,004 | $90.87 | −$1.09M | 33,977 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Exercise / conversion · M | +26,666 | — | — | 45,981 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Disposition to Issuer · D | −11,656 | $90.87 | −$1.06M | 19,315 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Withheld — tax / exercise cost · F | −9,331 | $90.87 | −$848K | 30,971 |
| Kosecoff Jacqueline B | EVP, Pharmaceutical Services | Dec 20 | Exercise / conversion · M | +20,987 | — | — | 40,302 |
| Garrett Sharon D | EVP, Enterprise Services | Dec 20 | Disposition to Issuer · D | −233 | $90.87 | −$21.2K | 0 |
| Garrett Sharon D | EVP, Enterprise Services | Dec 20 | Disposition to Issuer · D | −10,000 | $90.87 | −$909K | 0 |
| Garrett Sharon D | EVP, Enterprise Services | Dec 20 | Disposition to Issuer · D | −5,427 | $90.87 | −$493K | 10,000 |
| Garrett Sharon D | EVP, Enterprise Services | Dec 20 | Withheld — tax / exercise cost · F | −4,573 | $90.87 | −$416K | 15,427 |
| Garrett Sharon D | EVP, Enterprise Services | Dec 20 | Exercise / conversion · M | +10,000 | — | — | 20,000 |
| Garrett Sharon D | EVP, Enterprise Services | Dec 20 | Disposition to Issuer · D | −7,234 | $90.87 | −$657K | 10,000 |
| Garrett Sharon D | EVP, Enterprise Services | Dec 20 | Withheld — tax / exercise cost · F | −6,099 | $90.87 | −$554K | 17,234 |
Loading...